^
No biomarker
Nasopharyngeal Carcinoma
toripalimab
Sensitive
:
A1
No biomarker
Nasopharyngeal Carcinoma
GC
Sensitive
:
A2
No biomarker
Nasopharyngeal Carcinoma
carboplatin + paclitaxel
Sensitive
:
A2
No biomarker
Nasopharyngeal Carcinoma
DP
Sensitive
:
A2
No biomarker
Nasopharyngeal Carcinoma
TPF
Sensitive
:
A2
No biomarker
Nasopharyngeal Carcinoma
cetuximab
Sensitive
:
A2
No biomarker
Nasopharyngeal Carcinoma
oxaliplatin
Sensitive
:
A2
No biomarker
Nasopharyngeal Carcinoma
doxorubicin hydrochloride
Sensitive
:
A2
No biomarker
Nasopharyngeal Carcinoma
ifosfamide
Sensitive
:
A2
No biomarker
Nasopharyngeal Carcinoma
vinorelbine tartrate
Sensitive
:
A2
No biomarker
Nasopharyngeal Carcinoma
irinotecan
Sensitive
:
A2
No biomarker
Nasopharyngeal Carcinoma
capecitabine
Sensitive
:
A2
No biomarker
Nasopharyngeal Carcinoma
5-fluorouracil
Sensitive
:
A2
No biomarker
Nasopharyngeal Carcinoma
docetaxel
Sensitive
:
A2
No biomarker
Nasopharyngeal Carcinoma
paclitaxel
Sensitive
:
A2
No biomarker
Nasopharyngeal Carcinoma
nedaplatin
Sensitive
:
A2
No biomarker
Nasopharyngeal Carcinoma
cisplatin
Sensitive
:
A2
No biomarker
Nasopharyngeal Carcinoma
cisplatin + 5-fluorouracil
Sensitive
:
A2
No biomarker
Nasopharyngeal Carcinoma
cisplatin + paclitaxel + epirubicin
Sensitive
:
A2
No biomarker
Nasopharyngeal Carcinoma
cisplatin + docetaxel
Sensitive
:
A2
No biomarker
Nasopharyngeal Carcinoma
cisplatin + paclitaxel
Sensitive
:
A2
No biomarker
Nasopharyngeal Carcinoma
cetuximab
Sensitive
:
A2
No biomarker
Nasopharyngeal Carcinoma
carboplatin + gemcitabine
Sensitive
:
A2
No biomarker
Nasopharyngeal Carcinoma
carboplatin
Sensitive
:
A2
VERI is free for non-commercial use, no login needed.
Content on this site is for research purposes only and is not intended  to be a substitute for medical advice.
For commercial access, including additional premium features, please contact us.
By using VERI, you are agreeing to our